Therapeutic efficacy of fixed dose artesunate-mefloquine for the treatment of acute, uncomplicated Plasmodium falciparum malaria in Kampong Speu, Cambodia

Malaria Journal

Volumn 12, Issue 1, 2013, Pages

  Leang, Rithea ^a   Ros, Sakun ^a   Duong, Socheat ^a   Navaratnam, Visweswaran ^b   Lim, Pharath ^a   Ariey, Frédéric ^c   Kiechel, Jean René ^d   Ménard, Didier ^c   Taylor, Walter Rj ^a,e  

^a National Centre for Parasitology Entomology and Malaria Control   (Cambodia)

^b Drugs for Neglected Diseases Initiative   (Malaysia)

^c INSTITUT PASTEUR DU CAMBODGE   (Cambodia)

^d Drugs for Neglected Diseases Initiative   (Switzerland)

^e GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Artesunate; Cambodia; Drug resistance; Malaria; Mefloquine; Plasmodium falciparum

Indexed keywords

ARTESUNATE PLUS MEFLOQUINE; CHLOROQUINE; DIHYDROARTEMISININ; PIPERAQUINE; QUININE;

ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BLOOD EXAMINATION; CAMBODIA; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; GAMETOCYTE; GENOTYPING TECHNIQUE; HUMAN; IC 50; IN VITRO STUDY; MALARIA FALCIPARUM; MALE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SCHOOL CHILD; TREATMENT DURATION; TREATMENT FAILURE;

ADOLESCENT; ADULT; ANTIMALARIALS; ARTEMISININS; CAMBODIA; CHILD; CHILD, PRESCHOOL; DRUG COMBINATIONS; FEMALE; GENOTYPE; HUMANS; INHIBITORY CONCENTRATION 50; MALARIA, FALCIPARUM; MALE; MEFLOQUINE; MIDDLE AGED; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; RECURRENCE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84886068070     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-12-343     Document Type: Article

References (33)

1. Plasmodium falciparum resistant to chloroquine in Cambodia. Eyles DE, Hoo CC, Warren M, Sandosham AA, Am J Trop Med Hyg 1963 12 840 843 14072437
2. Origin and evolution of sulfadoxine resistant Plasmodium falciparum. Vinayak S, Alam MT, Mixson-Hayden T, McCollum AM, Sem R, Shah NK, Lim P, Muth S, Rogers WO, Fandeur T, Barnwell JW, Escalante AA, Wongsrichanalai C, Ariey F, Meshnick SR, Udhayakumar V, PLoS Pathog 2010 6 1000830 10.1371/journal.ppat. 1000830 20360965
3. In vivo response of multi-resistant Plasmodium falciparum infections to mefloquine and its combination with sulfadoxine/pyrimethamine in Cambodia. Denis MB, Kouznetsov RL, Giboda M, Folia Parasitol (Praha) 1991 38 187 188
4. Treatment of falciparum malaria with quinne and tetracycline or combined mefloquine/sulfadoxine/pyrimethamine on the Thai-Kampuchean border. Meek SR, Doberstyn EB, Gauzere BA, Thanapanich C, Nordlander E, Phuphaisan S, Am J Trop Med Hyg 1986 35 246 250 3513642 (Pubitemid 16055386)
5. Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia. Denis MB, Tsuyuoka R, Poravuth Y, Narann TS, Seila S, Lim C, Incardona S, Lim P, Sem R, Socheat D, Christophel EM, Ringwald P, Trop Med Int Health 2006 11 1360 1366 10.1111/j.1365-3156.2006.01690.x 16930257 (Pubitemid 44289723)
6. Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia. Denis MB, Tsuyuoka R, Lim P, Lindegardh N, Yi P, Top SN, Socheat D, Fandeur T, Annerberg A, Christophel EM, Ringwald P, Trop Med Int Health 2006 11 1800 1807 10.1111/j.1365-3156.2006. 01739.x 17176344 (Pubitemid 44813874)
7. Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia. Lim P, Alker AP, Khim N, Shah NK, Incardona S, Doung S, Yi P, Bouth DM, Bouchier C, Puijalon OM, Meshnick SR, Wongsrichanalai C, Fandeur T, Le Bras J, Ringwald P, Ariey F, Malar J 2009 8 11 10.1186/1475-2875-8-11 19138391
8. Efficacy and safety study of artesunate and mefloquine (A + M) combination therapy for the treatment of uncomplicated. Rithea L, Denis MB, Christophel EM, Ringwald P, Abdur R, Scoheat D, Plasmodium falciparum malaria in Veal Veng Cambodia. Phnom Penh: National Centre for Parasitology, Entomology and Malaria Control 2007 5
9. Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia. Rogers WO, Sem R, Tero T, Chim P, Lim P, Muth S, Socheat D, Ariey F, Wongsrichanalai C, Malar J 2009 8 10 10.1186/1475-2875-8-10 19138388
10. Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007. Lim P, Wongsrichanalai C, Chim P, Khim N, Kim S, Chy S, Sem R, Nhem S, Yi P, Duong S, Bouth DM, Genton B, Beck HP, Gobert JG, Rogers WO, Coppee JY, Fandeur T, Mercereau-Puijalon O, Ringwald P, Le Bras J, Ariey F, Antimicrob Agents Chemother 2010 54 2135 2142 10.1128/AAC.01304-09 20194689
11. A randomized open study to assess the efficacy and tolerability of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Cambodia. Janssens B, Van Herp M, Goubert L, Chan S, Uong S, Nong S, Socheat D, Brockman A, Ashley EA, Van Damme W, Trop Med Int Health 2007 12 251 259 10.1111/j.1365-3156.2006.01786.x 17300633
12. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison. Smithuis F, Kyaw MK, Phe O, Aye KZ, Htet L, Barends M, Lindegardh N, Singtoroj T, Ashley E, Lwin S, Stepniewska K, White NJ, Lancet 2006 367 2075 2085 10.1016/S0140-6736(06)68931-9 16798391 (Pubitemid 43949291)
13. Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010. Leang R, Barrette A, Bouth DM, Menard D, Abdur R, Duong S, Ringwald P, Antimicrob Agents Chemother 2013 57 818 826 10.1128/AAC.00686-12 23208711
14. Evidence of artemisinin-resistant malaria in western Cambodia. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM, N Engl J Med 2008 359 2619 2620 10.1056/NEJMc0805011 19064625
15. The story of artesunate-mefloquine (ASMQ), innovative partnerships in drug development: case study. Wells S, Diap G, Kiechel JR, Malar J 2013 12 68 10.1186/1475-2875-12-68 23433060
16. World Health Organization, Methods for surveillance of antimalarial drug efficacy Geneva: World Health Organization 2009
17. Annual Progress Report of the National Centre for Parasitology. CNM, Entomology and Malaria Control Phnom Penh: National Centre for Parasitology, Entomology and Malaria Control 2007 32
18. Communicable diseases cluster: severe falciparum malaria. World Health Organization, Trans R Soc Trop Med Hyg 2000 94 1 S90 Suppl 1 11103309
19. Genotyping of Plasmodium falciparum infections by PCR: a comparative multicentre study. Färnert A, Arez AP, Babiker HA, Beck HP, Benito A, Björkman A, Bruce MC, Conway DJ, Day KP, Henning L, Mercereau-Puijalon O, Ranford-Cartwright LC, Rubio JM, Snounou G, Walliker D, Zwetyenga J, Do Rosario VE, Trans R Soc Trop Med Hyg 2001 95 225 232 10.1016/S0035-9203(01)90175-0 11355566 (Pubitemid 34947393)
20. WHO, Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated Falciparum Malaria Geneva: World Health Organization 2003
21. Medicines for Malaria Venture, World Health Organization, Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations Geneva: World Health Organization 2008
22. Adverse drug reactions: definitions, diagnosis, and management. Edwards IR, Aronson JK, Lancet 2000 356 1255 1259 10.1016/S0140-6736(00)02799-9 11072960
23. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Desjardins RE, Canfield CJ, Haynes JD, Chulay JD, Antimicrob Agents Chemother 1979 16 710 718 10.1128/AAC.16.6.710 394674 (Pubitemid 10082023)
24. Icestimator http://www.antimalarial-icestimator.net/
25. World Health Organization, Global report on antimalarial drug efficacy and drug resistance: 2000-2010 Geneva: World Health Organization 2010
26. In vivo parasitological measures of artemisinin susceptibility. Stepniewska K, Ashley E, Lee SJ, Anstey N, Barnes KI, Binh TQ, D'Alessandro U, Day NP, De Vries PJ, Dorsey G, Guthmann JP, Mayxay M, Newton PN, Olliaro P, Osorio L, Price RN, Rowland M, Smithuis F, Taylor WR, Nosten F, White NJ, J Infect Dis 2010 201 570 579 10.1086/650301 20085495
27. Use of weight-for-age-data to optimize tablet strength and dosing regimens for a new fixed-dose artesunate-amodiaquine combination for treating falciparum malaria. Taylor WR, Terlouw DJ, Olliaro PL, White NJ, Brasseur P, Ter Kuile FO, Bull World Health Organ 2006 84 956 964 10.2471/BLT.06.031492 17242831 (Pubitemid 44901752)
28. Early parasitological response following artemisinin-containing regimens: a critical review of the literature. Das D, Price RN, Bethell D, Guerin PJ, Stepniewska K, Malar J 2013 12 125 10.1186/1475-2875-12-125 23602021
29. Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in Western Cambodia. Witkowski B, Khim N, Chim P, Kim S, Ke S, Kloeung N, Chy S, Duong S, Leang R, Ringwald P, Dondorp AM, Tripura R, Benoit-Vical F, Berry A, Gorgette O, Ariey F, Barale JC, Mercereau-Puijalon O, Menard D, Antimicrob Agents Chemother 2013 57 914 923 10.1128/AAC.01868-12 23208708
30. Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies. Witkowski B, Amaratunga C, Khim N, Sreng S, Chim P, Kim S, Lim P, Mao S, Sopha C, Sam B, Anderson JM, Duong S, Chuor CM, Taylor WR, Suon S, Mercereau-Puijalon O, Fairhurst RM, Menard D, Lancet Infect Dis. 2013
31. In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up. Stepniewska K, Taylor WR, Mayxay M, Price R, Smithuis F, Guthmann JP, Barnes K, Myint HY, Adjuik M, Olliaro P, Pukrittayakamee S, Looareesuwan S, Hien TT, Farrar J, Nosten F, Day NP, White NJ, Antimicrob Agents Chemother 2004 48 4271 4280 10.1128/AAC.48.11.4271-4280. 2004 15504852 (Pubitemid 39434886)
32. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Price RN, Uhlemann AC, Brockman A, McGready R, Ashley E, Phaipun L, Patel R, Laing K, Looareesuwan S, White NJ, Nosten F, Krishna S, Lancet 2004 364 438 447 10.1016/S0140-6736(04)16767-6 15288742 (Pubitemid 39036891)
33. Exploring the contribution of candidate genes to artemisinin resistance in Plasmodium falciparum. Imwong M, Dondorp AM, Nosten F, Yi P, Mungthin M, Hanchana S, Das D, Phyo AP, Lwin KM, Pukrittayakamee S, Lee SJ, Saisung S, Koecharoen K, Nguon C, Day NP, Socheat D, White NJ, Antimicrob Agents Chemother 2010 54 2886 2892 10.1128/AAC.00032-10 20421395